Abstract
The clinical presentation of late-life depression is highly heterogeneous and likely influenced by the co-presence of somatic diseases. Using a network approach, this study aims to explore how depressive symptoms are interconnected with each other, as well as with different measures of somatic disease burden in older adults. We examined cross-sectional data on 2860 individuals aged 60+ from the Swedish National Study on Aging and Care in Kungsholmen, Stockholm. The severity of sixteen depressive symptoms was clinically assessed with the Comprehensive Psychopathological Rating Scale. We combined data from individual clinical assessment and health-registers to construct eight system-specific disease clusters (cardiovascular, neurological, gastrointestinal, metabolic, musculoskeletal, respiratory, sensory, and unclassified), along with a measure of overall somatic burden. The interconnection among depressive symptoms, and with disease clusters was explored through networks based on Spearman partial correlations. Bridge centrality index and network loadings were employed to identify depressive symptoms directly connecting disease clusters and depression. Sadness, pessimism, anxiety, and suicidal thoughts were the most interconnected symptoms of the depression network, while somatic symptoms of depression were less interconnected. In the network integrating depressive symptoms with disease clusters, suicidal thoughts, reduced appetite, and cognitive difficulties constituted the most consistent bridge connections. The same bridge symptoms emerged when considering an overall measure of somatic disease burden. Suicidal thoughts, reduced appetite, and cognitive difficulties may play a key role in the interconnection between late-life depression and somatic diseases. If confirmed in longitudinal studies, these bridging symptoms could constitute potential targets in the prevention of late-life depression.
Introduction
Late-life depression represents a major public health concern due to its impact on disability, quality of life, and health-related behaviours [1]. Compared to younger individuals, depression in older adults is presumed to have different pathophysiology and clinical presentation, with a prominent role of medical comorbidities [2,3,4]. Chronic somatic diseases involve neurobiological alterations, such as microvascular brain damage, autonomic, immunometabolic, or neuroendocrine dysregulation, which can have important implications for the risk of late-life depression [4]. These mechanisms coexist and interact with an array of psychological reactions to illness, that are closely related to depression, namely demoralization, anxiety, or death thoughts [4,5,6]. Hence, chronic somatic diseases are likely an important factor shaping the pathophysiology and clinical heterogeneity of late-life depression [7,8,9]. Yet, the interplay between the broad account of somatic conditions in late-life and individual depressive symptoms remains unclear.
Recently, a network approach has been increasingly adopted in psychiatric research. It enables to examine the structure of psychiatric syndromes by highlighting symptom relationships, and by identifying the most interconnected symptoms [10, 11]. The network theory of mental disorder is based on the notion that psychiatric disorders emerge from symptoms that cause and interact with each other in a reinforcing manner and via feedback loops, until they become self-sustained [10,11,12]. Each symptom of a mental disorder can become activated by other psychiatric symptoms or by stimuli that are external to the network. The burden of somatic diseases could be such external factor, introduced into the depressive symptom network via so-called bridge connections [10]. Such direct links between depressive symptoms and somatic disease burden may reflect either a causal process or a shared aetiological influence.
Network analysis has been previously used to visualize the structure of depressive symptoms in a large European sample of older community-dwellers, in which death wishes, depressed mood, and loss of interest were the most interconnected in the network, whereas somatic symptoms of sleep problems and loss of appetite were less interconnected [13]. Such framework has also helped uncover how clinical correlates of somatic diseases, such as pain and dyspnea, were linked to several depressive symptoms in individuals with chronic pain and chronic obstructive pulmonary disease, respectively [14, 15]. Yet, studies on older adults with multiple co-occurring diseases (i.e., multimorbidity), which detrimentally impact functional status, and increase the vulnerability to depression, are currently lacking [16,17,18]. Identifying whether late-life depression is associated with different somatic diseases through distinct bridge symptoms might hold clinical value for diagnostic and treatment purposes.
The aim of this study is to explore the role of somatic disease burden in the depressive symptom network of older adults. Specifically, we aim (i) to describe the structure of depressive symptoms in late life, and (ii) to identify bridge symptoms of depression directly linked to the different measures of somatic disease burden. We hypothesize that (i) system-specific clusters of somatic diseases would connect to different symptoms of the network, although we also expect some bridge connections to be shared, and (ii) that somatic symptoms of depression would emerge as especially relevant bridge symptoms between depression and somatic diseases.
Methods
Study population and participants
We used data from the Swedish National Study on Aging and Care in Kungsholmen (SNAC-K, www.snac-k.se), an ongoing prospective population-based cohort of individuals aged 60+ living in central Stockholm [19]. During the baseline assessments in 2001−2004, 3,363 people (73% participation rate) underwent a medical examination, neuropsychological evaluation, nurse interviews, and laboratory testing. SNAC-K has been linked to the Swedish National Patient Register, which extends participants’ clinical status with information on inpatient and outpatient care.
As part of the eligibility criteria, we excluded one participant with intellectual disability and 310 with definite, probable, or questionable dementia according to DSM-IV criteria [20]. Additional exclusions due to missing data were made as follows: ten participants who refused to undergo the medical examination and 182 with missing information on the psychiatric assessment, resulting in an analytical sample of 2,860 individuals (study population flowchart in Supplementary Fig. 1).
Written informed consent was obtained from all participants or from their next of kin in the case of cognitive impairment. SNAC-K received approval from the Ethics Committee at Karolinska Institutet and the Regional Ethical Review Board in Stockholm.
Depressive symptoms
Psychiatric assessment was performed by trained physicians using the Comprehensive Psychopathological Rating Scale, a broad battery evaluating the presence and severity of psychiatric symptoms and observed behaviours [21]. In SNAC-K, a subset of the original version comprising 27 psychiatric features was used to assess mood, behavioural, cognitive, and somatic symptoms on a 0−6 scale of severity (i.e., absent to severe). We excluded the symptoms of reduced sexual interest and morbid jealousy because of the high missing rates (35% and 41%, respectively) and four items not pertaining to depression (suspicion, fabrication, disinhibition, difficulty gauging social boundaries; see Supplementary Table 1), resulting in a total of 21 symptoms.
Somatic disease burden
Medical diagnoses in SNAC-K were based on clinical examination, medical history, laboratory data, and medication use, whereas the linkages to inpatient and outpatient clinical registers increased the accuracy of diagnostic episodes. Chronic diseases were coded according to a previously developed operationalization in SNAC-K, whereby a multidisciplinary panel of clinicians and researchers reached a consensus on the definition of chronic diseases as those with a prolonged duration, and resulting in either (1) residual disability or worsened quality of life, or (2) requirement of a long period of care, treatment, or rehabilitation [22]. As a result, 918 ICD-10 codes identifying chronic diseases were selected, and further categorized into 60 homogeneous groups in accordance with clinical criteria and relevance for old age [22].
To obtain the measures of somatic disease burden, psychiatric conditions (depression and mood disorders, schizophrenia and delusional disorders, neurotic and stress-related disorders, sleep disorders, and other psychiatric disorders) were excluded from the list of chronic disease categories. Somatic conditions were further grouped into seven clusters based on the main bodily systems: cardiovascular, metabolic, neurological, musculoskeletal, gastrointestinal, respiratory, and sensory. An unclassified cluster was also constructed, comprising diseases that were largely asymptomatic (e.g., chronic kidney disease) or could not be distinctively classified into any of the defined groups (e.g cancer, allergy; see Supplementary Table 2 for more information). The count of diseases within each cluster was used as a measure of somatic disease burden, while the total count of diseases was used as the index of the overall somatic disease burden, similar to previous studies [17].
Statistical analyses
Network estimation
Analyses were based on the network approach to psychopathology [10]. In a symptom network, variables are represented as nodes connected with lines of varying thickness (i.e., edges), depending on the strength of the correlation between the nodes. The network visualization employs the Fruchterman−Reingold algorithm that places highly correlated nodes closer together and centrally in the network, while the nodes with weaker connections are positioned peripherally [23].
Network estimation was based on Spearman partial correlations: we computed the unregularized Gaussian Graphical Model using ggmModSelect command of the qgraph (version 1.6.5) package in R. Briefly, ggmModSelect employs an iterative process to select the optimal Gaussian Graphical Model without regularization based on the extended Bayesian information criterion (for more details, http://psychosystems.org/qgraph_1.5). Unregularized models have been suggested for samples where participants greatly outnumber the nodes [24].
Network estimation was preceded by the identification of redundant depressive symptoms, which were then merged with an averaging approach (see Supplementary Text for details) [25]. The inclusion of highly correlated symptoms in a network, a phenomenon termed topological overlap, can result in biased estimates of connections and centrality indices [26].
Three networks were estimated separately: (i) the network exploring the overall structure of depressive symptoms, (ii) the network integrating measures of disease count within each of the eight somatic clusters, and (iii) the network utilizing the overall count of somatic diseases instead.
Network measures
Network descriptives were examined using the following metrics: distribution degree, network density, small-worldness (we refer to the Supplementary Text for the description of the specific measures).
To identify depressive symptoms with greater connectivity, we computed the centrality index of expected influence, which for a given node is the standardized sum of all of its correlation coefficients [27]. Additionally, we used the mgm R package (version 1.2-9) to estimate node predictability [28], which indicates the variance in the node accounted for by its neighbouring connections [29, 30].
To detect bridge connections, i.e., those depressive symptoms that are directly connected to the different measures of somatic disease burden, we estimated the bridge centrality index of expected influence using the networktools package in R (version 1.2.3) [31]. This requires an a priori designation of the groups of nodes that are expected to be linked through bridge connections, which, in our case, were depressive symptoms and somatic disease clusters. The bridge’s expected influence quantifies the standardized sum of node’s edges directed to the nodes of another network, e.g., from the node of cardiovascular burden to all depressive symptoms [32]. Further, we computed the network cross-loadings, a recently developed measure that allows to estimate effect sizes of bridge connections, for which cut-off criteria have also been proposed (see Supplementary Text for details) [33, 34].
Sensitivity analyses
To evaluate the robustness of the obtained bridge symptoms, we computed multi-adjusted networks by adding nodes for age, sex, and education, as the partial correlations (i.e., edges in the network) are mutually adjusted for each included node [35]. Due to the scale of the variables included in the model (nominal for sex, ordinal for education), we used mixed-models analyses which can handle data on different scales (for more details, see Supplementary Text) that was carried out with the mgm package [28].
The stability of the network was estimated with a case-dropping bootstrap procedure using bootnet (version 1.4.3) [23], whereby a subset of random cases was gradually removed and the centrality measures from these reduced samples were compared with the original. The correlation stability coefficient (CS-C) was derived as the largest proportion of participants that could be randomly dropped with the correlation of centrality measures between the reduced and the original sample remaining at 0.7 or higher (a CS-C of 0.5 is indicative of a stable network).
All data preparation was conducted in STATA 16 (StataCorp, College Station, Texas, USA), while all network-related analyses were carried out in R (version 4.0.0).
Results
Sample characteristics
Participants excluded due to missing information on any depressive symptom (n = 182), were more likely to be older, more cognitively impaired, and with a higher number of chronic diseases compared to those included in the analyses (p < 0.01 for all, data not shown).
Table 1 reports the characteristics of the 2680 participants included in the analyses. Individuals presenting burdensome depressive symptomatology comprised 12% of the analytical sample. They were more likely to be older, female, less educated, more cognitively impaired, and to have a higher burden of somatic conditions, both in terms of overall disease count and specific clusters.
Out of the 21 depressive symptoms considered, 10 redundant items were combined, resulting in a total of 16 depressive symptoms that were used in the analyses (Supplementary Table 3). The means and standard deviations of the depressive symptom scores in the total sample, and according to somatic disease burden are presented in Supplementary Table 4. Depressive symptoms with the highest mean scores were cognitive difficulties, reduced sleep, lack of initiative, and anxiety. Individuals with 2+ somatic diseases presented with significantly higher mean scores for several depressive symptoms, including lack of initiative, anxiety, reduced appetite, cognitive difficulties, and suicidal thoughts, compared to those with 0−1 conditions.
Network of depressive symptoms
A network of 16 depressive symptoms is shown in Fig. 1, panel A. All depressive symptoms were positively interconnected around sadness, pessimism, anxiety, and suicidal thoughts, which exhibited the highest centrality and predictability estimates (Fig. 1, panel B). The strongest connections pertained to the edges between sadness and pessimism, sadness and slowness, and sadness and suicidal thoughts. The connections between the inability to feel and social seclusion, as well as between inability to feel and suicidal thoughts were also strong, as were the edges between cognitive difficulties and lack of initiative (Supplementary Fig. 2 for correlation matrix). The network presented an indication of small-world characteristics, i.e., high clustering and short path lengths (ω index of 0.36; see Supplementary Fig. 3 and Table 5 for more network descriptives).
Blue connections indicate positive correlations; the thickness of lines is proportional to the strength of the correlation. The darker outer circle of each node represents the predictability, i.e., the proportion of variance explained by its neighbouring nodes. Expected influence is the standardized sum of the weights of all direct connections between a specific symptom and all other symptoms.
Network of depressive symptoms and somatic disease burden clusters
Figure 2, panel A, depicts the network in which the clusters of somatic disease burden were added to the network of depressive symptoms. The network presented as 24 fully interrelated nodes, with mostly positive associations, although two negative edges were also identified (see Supplementary Fig. 4 for the correlation matrix). The network exhibited an indication of being small-world (ω = 0.43; see Supplementary Fig. 3 and Table 5 for more descriptives).
Blue connections indicate positive correlations; red, negative correlations; thickness of lines is proportional to the strength of the correlation. The darker outer circle of each node represents the predictability, i.e., the proportion of variance explained by its neighbouring nodes. The table (panel B) reports bridge connections between somatic disease groups and depressive symptoms. #Bridge connection preserved after including nodes for age, sex, and education. †Bridge connection emergent in the network including nodes for age, sex, and education.
Direct interconnections between depressive symptoms and somatic disease burden clusters, i.e., bridge connections, are summarized in Fig. 2, panel B. We list bridge connections from a crude network, as well as from the network including nodes for age, sex, and education. Fourteen bridge connections were identified, mostly linking somatic disease groups with symptoms on the periphery of the depressive symptoms network. Cognitive difficulties shared direct connections with neurological, sensory, and respiratory burden, whereas reduced appetite connected with neurological, cardiovascular, sensory, metabolic, and unclassified disease clusters. Conversely, suicidal thoughts and anxiety, two of the most interconnected nodes in the depressive symptoms network, presented direct links to sensory and gastrointestinal burden. Unique connections were identified between slowness and neurological burden, hostility and sensory burden, lack of initiative and unclassified burden, and, finally, worthlessness and musculoskeletal burden. The bridge centrality index of expected influence indicated that cognitive difficulties, suicidal thoughts, and reduced appetite exhibited the highest connectivity with the various clusters of somatic disease burden (Fig. 3). This was confirmed by the network cross-loadings, which suggested their effect sizes being substantively meaningful (0.144, 0.099, and 0.09 for reduced appetite, cognitive difficulties, and suicidal thoughts, respectively; see Supplementary Table 6 for all network loadings).
Bridge expected influence expresses a node’s connectivity with the other network. The higher the centrality, the greater the connection between a node of one network (e.g., depressive symptom) with the nodes of the other network (e.g., somatic disease clusters).
Network of depressive symptoms and overall somatic disease burden
Figure 4, panel A, displays the depressive symptoms network integrating an overall measure of somatic burden. Parallel to the findings from the network incorporating system-specific clusters of diseases, reduced appetite, cognitive difficulties, suicidal thoughts, and lack of initiative emerged as bridge symptoms, connecting directly to the node of overall somatic burden (see Supplementary Fig. 5 for correlation matrix).
Blue connections indicate positive correlations; the thickness of lines is proportional to the strength of the correlation. The darker outer circle of each node represents the predictability, i.e., the proportion of the variance in a node explained by its neighbouring nodes. The table (panel B) reports bridge connections between the overall somatic burden and depressive symptoms. #Bridge connection preserved after including nodes for age, sex, and education.
Sensitivity analyses
Including nodes for age, sex, and education partially attenuated the bridge connections in the two networks. As summarized in Fig. 2, panel B, the following bridge connections were preserved in the network incorporating somatic disease clusters: cognitive difficulties and slowness remained connected with neurological burden, anxiety with gastrointestinal burden, cognitive difficulties and suicidal thoughts with sensory burden, and worthlessness with musculoskeletal burden. As for the association with the overall somatic burden (Fig. 4, panel B), connections with reduced appetite and cognitive difficulties persisted after adjustment.
The networks were highly stable, as all correlation stability coefficients were >0.9, indicating that the correlation of node centrality estimates between a reduced sample and the original sample was at least 0.7 after randomly excluding 90% of observations from the original sample (Supplementary Figs. 6−8).
Discussion
Using a network approach, we examined the interconnection among depressive symptoms, as well as between depressive symptoms and different measures of somatic disease burden in a population-based sample of older adults. The network of depressive symptoms was structured around the highly interconnected symptoms of sadness, pessimism, anxiety, and suicidal thoughts. While we did uncover some unique symptom-disease cluster connections, the symptoms of reduced appetite, suicidal thoughts, and cognitive difficulties emerged as the most substantive bridge symptoms linking depression with several clusters of disease burden. Notably, these symptoms were also connected with the overall burden of somatic diseases, thus suggesting their potentially overarching influence. To our knowledge, this is the first study examining the interconnections between depression and somatic health in late life by focusing on individual depressive symptoms.
The network of depressive symptoms in late life
This study extends the knowledge on the interconnectedness of depressive symptoms in late life. Sadness, pessimism, anxiety, and suicidal thoughts were the most interconnected symptoms of the network, while symptoms pertaining to somatic and cognitive domains, such as reduced appetite, reduced sleep, and cognitive difficulties, were less integrated. These findings are consistent with previous studies, where somatic features have shown a lower interconnectedness with other depressive symptoms [13, 36]. However, somatic and cognitive symptoms had the highest mean level scores in our sample, a finding which has also been observed in previous studies involving older adults [3, 13]. This observation has led to the hypothesis that depression in late life may be characterized by a more pronounced somatic clinical phenotype [37]. Still, we observed that the less integrated symptoms (e.g., reduced appetite, reduced sleep, and cognitive difficulties) were fully incorporated into the network through links to the more interconnected depressive symptoms, including sadness, anxiety, suicidal thoughts, and lack of initiative. Following the theory of psychological network, connections may represent sequential chains of symptoms, leading to the sustained syndrome of depression [10]. From a clinical perspective, the hypothesis posits that highly interconnected symptoms may be viewed as targets for intervention to deactivate the entire depressive network at the individual level [12]. However, evidence from network studies linking cross-sectional estimates of symptom connectivity with symptom change in individuals over time has produced mixed results [38,39,40,41]. Thus, our results should be interpreted considering the cross-sectional study design adopted here. Whether these highly interconnected symptoms are likely to be influential in some individuals’ depressive networks needs to be confirmed with longitudinal data.
Bridge connections between depressive symptoms and somatic burden
Both more and less interconnected symptoms (i.e., suicidal thoughts, reduced appetite, and cognitive difficulties) were consistently linked with several measures of somatic burden covering the neurological, cardiovascular, sensory, and respiratory systems. These very same symptoms were also associated with the overall measure of disease burden. This apparent generalizability hints at the possible existence of common depressive features across different patterns of somatic diseases as well as overall multimorbidity. Overlapping symptomatology, or a complex causal structure, may underpin this association between somatic conditions and depression. Answering such questions requires future research.
Suicidal thoughts, a severe depressive symptom, were linked to gastrointestinal and sensory burden, as well as to the overall somatic disease burden. These findings are in line with previous studies where sensory loss was associated with suicidal ideation, and gastrointestinal disease was linked to higher rates of suicide after hospitalization [42, 43]. A recent meta-analysis concluded that individuals with physical multimorbidity were more likely to present current and future suicidal ideation [44], as well as higher suicide risk, especially when depression was comorbid [45]. In our study, the node of suicidal thoughts shared high connectivity with core depressive symptoms, such as sadness and inability to feel. This may suggest that older people with high clinical complexity may experience death wishes when also faced with other frequent depressive symptoms. Besides the comorbidity of depression, factors that may contribute to suicidal ideation in multimorbid individuals include functional impairment, lack of coping capacities, and chronic pain [46]. Finally, neurobiological evidence has linked suicide and suicidal ideation with impairment of body systems controlling stress response, immune function, and inflammation, which are also involved in multimorbidity [47].
We observed that reduced appetite, a less interconnected node, was associated with multiple somatic groups (i.e., cardiovascular, neurological, metabolic, and unclassified), as well as with the overall somatic burden. These findings are in line with the hypothesis that somatic features of depression may constitute a bridge symptom to somatic diseases, possibly due to the overlapping symptomatology. Notably, other somatic depressive symptoms in the network, such as reduced sleep or autonomic disturbances, did not emerge as bridging symptoms in any of our analyses. Older adults often experience a reduction in appetite due to conditions such as heart failure and chronic kidney disease, which can lead to the loss of weight and sarcopenia; reduced appetite can also present as a side effect of several medications (e.g., opioids, antiepileptics) [48]. It remains unclear, however, whether the experience of reduced appetite in the context of high somatic burden may ease the transition to depression. In our network, inability to feel and lack of initiative were the two nodes primarily connecting reduced appetite with the core depressive symptoms. These three depressive symptoms are thought to express impaired motivational and reward processing, which involves dopaminergic neural pathways that are typically impaired in old age [49,50,51].
Finally, we showed that the node for cognitive difficulties was less interconnected with other symptoms in the network, although it was characterized by the highest mean score in the study population. Cognitive difficulties displayed connections with sensory, neurological, and respiratory disease groups, as well as with the overall somatic burden. The association of neurological burden with both cognitive difficulties and slowness, exemplifies the likely symptom overlap between neurological diseases and depression, whereby depression can often precede several neurological conditions, but also manifest as one of their psychiatric symptoms. Furthermore, depression in late life is intimately linked to disrupted cognitive processes related to fronto-limbic abnormalities, often due to high somatic burden [4]. The relevance of cognitive difficulties is illustrated by this node’s direct connections with both central and peripheral depressive symptoms of the network, likely contributing to the sustainment of the overall depressive syndrome. Further, the association of cognitive difficulties with somatic groups beyond neurological diseases, as well as with the overall burden, underscores the wide-ranging implications of cognitive impairment for physical health and function that have been shown in previous studies [52,53,54,55].
Limitations and strengths
This study has several strengths, including its population-based design, large sample size, and high participation rate (73%). The psychiatric assessment of depressive symptoms was part of an extensive examination carried out by trained physicians, whereas the clinical status was comprehensively assessed by combining medical assessment, medication reviews, and linkage to inpatient and outpatient national registries.
Several limitations need to be considered. First, we employed cross-sectional data, which hinders any conclusion about the temporality between somatic burden and depressive symptoms. Future studies should explore these associations longitudinally. Second, in networks incorporating two communities, bridge centrality may not effectively identify substantive connections, as it only provides rank-order indications. As a robustness check of our findings, we used network cross-loadings to evaluate bridge connections based on effect sizes, with reduced appetite, cognitive difficulties, and suicidal thoughts remaining as substantively meaningful bridges. Third, we performed basic adjustments only for age, sex, and education, which is arguably sufficient for a descriptive study that aims to be hypothesis-generating. However, future longitudinal studies may consider a broader set of potential confounders when investigating causal associations. Fourth, the data reduction procedure to combine redundant depressive items may have led to a loss of unique information pertaining to the depression assessment. To limit the loss of clinically informative nodes, we only aggregated nodes with both correlational and clinical overlap. Fifth, our classification of the somatic disease clusters may encompass high biological heterogeneity within each category. Future studies may overcome this issue by employing biological measures (e.g., inflammatory biomarkers, hyphothalamic-pituitary-adrenal axis correlates) when exploring the biological underpinning of depression in the context of somatic health. Last, the exclusion of participants with missing information on depressive symptoms may have led to the omission of older and frailer study participants.
Conclusions
We showed that symptoms of sadness, pessimism, anxiety, and suicidal thoughts were highly interconnected in the depressive network of older adults. Furthermore, reduced appetite, cognitive difficulties, and suicidal thoughts consistently emerged as bridge symptoms between the depressive and the somatic disease burden networks, both for specific disease patterns, as well as for the overall burden. These findings suggest that depressive symptoms may be differentially expressed by older individuals with high clinical complexity. Future longitudinal studies are warranted to verify whether targeting these bridge symptoms in multimorbid individuals may prevent the onset of depression.
Data availability
Access to SNAC-K original data (http://www.snac-k.se/) is available to the scientific community upon approval provided by the SNAC-K management and maintenance committee. Applications can be submitted to Maria Wahlberg (Maria.Wahlberg@ki.se) at the Aging Research Centre, Karolinska Institutet. Code is available upon request.
References
- 1.
Alexopoulos GS. Depression in the elderly. Lancet. 2005;365:1961–70.
- 2.
Hegeman JM, Kok RM, van der Mast RC, Giltay EJ. Phenomenology of depression in older compared with younger adults: meta-analysis. Br J Psychiatry. 2012;200:275–81.
- 3.
Schaakxs R, Comijs HC, Lamers F, Beekman ATF, Penninx BWJH. Age-related variability in the presentation of symptoms of major depressive disorder. Psychol Med. 2017;47:543–52.
- 4.
Alexopoulos GS. Mechanisms and treatment of late-life depression. Transl Psychiatry. 2019;9:188.
- 5.
Belvederi Murri M, Caruso R, Ounalli H, Zerbinati L, Berretti E, Costa S, et al. The relationship between demoralization and depressive symptoms among patients from the general hospital: network and exploratory graph analysis. J Affect Disord. 2020;276:137–46.
- 6.
Gold SM, Köhler-Forsberg O, Moss-Morris R, Mehnert A, Miranda JJ, Bullinger M, et al. Comorbid depression in medical diseases. Nat Rev Dis Prim. 2020;6:69.
- 7.
Milaneschi Y, Lamers F, Berk M, Penninx BWJH. Depression heterogeneity and its biological underpinnings: toward immunometabolic depression. Biol Psychiatry. 2020;88:369–80.
- 8.
Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman AT, Penninx BW. Evidence for a differential role of HPA-axis function, inflammation, and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry. 2013;18:692–9.
- 9.
Penninx B, Milaneschi Y, Lamers F, Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013;11:14.
- 10.
Borsboom D. A network theory of mental disorders. World Psychiatry. 2017;16:5–13.
- 11.
Robinaugh DJ, Hoekstra RHA, Toner ER, Borsboom D. The network approach to psychopathology: a review of the literature 2008−2018 and an agenda for future research. Psychol Med. 2020;50:353–66.
- 12.
Cramer AO, van Borkulo CD, Giltay EJ, van der Maas HL, Kendler KS, Scheffer M, et al. Major depression as a complex dynamic system. PLoS One. 2016;11:e0167490.
- 13.
Belvederi Murri M, Amore M, Respino M, Alexopoulos GS. The symptom network structure of depressive symptoms in late-life: results from a European population study. Mol Psychiatry. 2018;25:1447–56.
- 14.
Schuler M, Wittmann M, Faller H, Schultz K. The interrelations among aspects of dyspnea and symptoms of depression in COPD patients—a network analysis. J Affect Disord. 2018;240:33–40.
- 15.
Gómez Penedo JM, Rubel JA, Blättler L, Schmidt SJ, Stewart J, Egloff N, et al. The complex interplay of pain, depression, and anxiety symptoms in patients with chronic pain: a network approach. Clin J Pain. 2020;36:249–59.
- 16.
Triolo F, Harber-Aschan L, Belvederi Murri M, Calderón-Larrañaga A, Vetrano DL, Sjöberg L, et al. The complex interplay between depression and multimorbidity in late life: risks and pathways. Mech Ageing Dev. 2020;192:111383.
- 17.
Vetrano DL, Rizzuto D, Calderón-Larrañaga A, Onder G, Welmer AK, Bernabei R, et al. Trajectories of functional decline in older adults with neuropsychiatric and cardiovascular multimorbidity: a Swedish cohort study. PLoS Med. 2018;15:e1002503.
- 18.
Vetrano DL, Roso-Llorach A, Fernández S, Guisado-Clavero M, Violán C, Onder G, et al. Twelve-year clinical trajectories of multimorbidity in a population of older adults. Nat Commun. 2020;11:3223.
- 19.
Lagergren M, Fratiglioni L, Hallberg IR, Berglund J, Elmståhl S, Hagberg B, et al. A longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC). Aging Clin Exp Res. 2004;16:158–68.
- 20.
Fratiglioni L, Grut M, Forsell Y, Viitanen M, Winblad B. Clinical diagnosis of Alzheimer’s disease and other dementias in a population survey: agreement and causes of disagreement in applying diagnostic and statistical manual of mental disorders, revised third edition, criteria. Arch Neurol. 1992;49:927–32.
- 21.
Åsberg M, Montgomery SA, Perris C, Schalling D, Sedvall G. A comprehensive psychopathological rating scale. Acta Psychiatr Scand. 1978;57:5–27.
- 22.
Calderón-Larrañaga A, Vetrano DL, Onder G, Gimeno-Feliu LA, Coscollar-Santaliestra C, Carfí A, et al. Assessing and measuring chronic multimorbidity in the older population: A proposal for its operationalization. J Gerontol A Biol Sci Med Sci. 2017;72:1417–23.
- 23.
Epskamp S, Borsboom D, Fried EI. Estimating psychological networks and their accuracy: a tutorial paper. Behav Res. Methods. 2018;50:195–212.
- 24.
Williams DR, Rast P. Back to the basics: rethinking partial correlation network methodology. Br J Math Stat Psychol. 2020;73:187–212.
- 25.
Golino H, Christensen, AP. EGAnet: Exploratory graph analysis—a framework for estimating the number of dimensions in multivariate data using network psychometrics. R package version 0.9.5 edn2020.
- 26.
Contreras A, Nieto I, Valiente C, Espinosa R, Vazquez C. The study of psychopathology from the network analysis perspective: a systematic review. Psychother Psychosom. 2019;88:71–83.
- 27.
Borsboom D, Cramer AO. Network analysis: an integrative approach to the structure of psychopathology. Annu Rev Clin Psychol. 2013;9:91–121.
- 28.
Haslbeck JMB, Waldorp LJ. mgm: estimating time-varying mixed graphical models in high-dimensional data. J. Stat. Softw.2020;93:46
- 29.
Haslbeck JMB, Fried EI. How predictable are symptoms in psychopathological networks? A reanalysis of 18 published datasets. Psychol Med. 2017;47:2767–76.
- 30.
Haslbeck JMB, Waldorp LJ. How well do network models predict observations? On the importance of predictability in network models. Behav Res Methods. 2018;50:853–61.
- 31.
Jones P. networktools: Tools for Identifying Important Nodes in Networks. R package version 1.2.3 edn (2020). https://CRAN.R-project.org/package=networktools.
- 32.
Jones PJ, Ma R, McNally RJ. Bridge centrality: a network approach to understanding comorbidity. Multivariate Behav Res. 2019;56:1–15.
- 33.
Christensen AP, Garrido, LE, Golino, H. What is bridge centrality? A comment on Jones, Ma, and McNally (2019). PsyArXiv. 2021. https://doi.org/10.31234/osf.io/a8svr.
- 34.
Christensen AP, Golino H. On the equivalency of factor and network loadings. Behav Res Methods. 2021;53:1563–80.
- 35.
Fried EI, von Stockert S, Haslbeck JMB, Lamers F, Schoevers RA, Penninx BWJH. Using network analysis to examine links between individual depressive symptoms, inflammatory markers, and covariates. Psychol Med. 2019;50:1–9.
- 36.
An MH, Park SS, You SC, Park RW, Park B, Woo HK, et al. Depressive symptom network associated with comorbid anxiety in late-life depression. Front Psychiatry. 2019;10:856.
- 37.
Alexopoulos GS, Borson S, Cuthbert BN, Devanand DP, Mulsant BH, Olin JT, et al. Assessment of late-life depression. Biol Psychiatry. 2002;52:164–74.
- 38.
Spiller TR, Levi O, Neria Y, Suarez-Jimenez B, Bar-Haim Y, Lazarov A. On the validity of the centrality hypothesis in cross-sectional between-subject networks of psychopathology. BMC Med. 2020;18:297.
- 39.
Rodebaugh TL, Tonge NA, Piccirillo ML, Fried E, Horenstein A, Morrison AS, et al. Does centrality in a cross-sectional network suggest intervention targets for social anxiety disorder? J Consult Clin Psychol. 2018;86:831–44.
- 40.
von Klipstein L, Borsboom D, Arntz A. The exploratory value of cross-sectional partial correlation networks: predicting relationships between change trajectories in borderline personality disorder. PLoS One. 2021;16:e0254496.
- 41.
Dablander F, Hinne M. Node centrality measures are a poor substitute for causal inference. Sci Rep. 2019;9:6846.
- 42.
Cosh S, Carrière I, Daien V, Tzourio C, Delcourt C, Helmer C. Sensory loss and suicide ideation in older adults: findings from the three-city cohort study. Int Psychogeriatr. 2019;31:139–45.
- 43.
Roberts SE, John A, Kandalama U, Williams JG, Lyons RA, Lloyd K. Suicide following acute admissions for physical illnesses across England and Wales. Psychol Med. 2018;48:578–91.
- 44.
Xiong F, Wang L, Shen L, Guo W, Li S, Guan Q. The relationship between multimorbidity and suicidal ideation: a meta-analysis. J Psychosom Res. 2020;138:110257.
- 45.
Webb RT, Kontopantelis E, Doran T, Qin P, Creed F, Kapur N. Suicide risk in primary care patients with major physical diseases: a case-control study. Arch Gen Psychiatry. 2012;69:256–64.
- 46.
Turecki G, Brent DA. Suicide and suicidal behaviour. Lancet. 2016;387:1227–39.
- 47.
Turecki G, Brent DA, Gunnell D, O'Connor RC, Oquendo MA, Pirkis J, et al. Suicide and suicide risk. Nat Rev Dis Prim. 2019;5:74.
- 48.
Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393:2636–46.
- 49.
Bäckman L, Nyberg L, Lindenberger U, Li SC, Farde L. The correlative triad among aging, dopamine, and cognition: current status and future prospects. Neurosci Biobehav Rev. 2006;30:791–807.
- 50.
Husain M, Roiser JP. Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nat Rev Neurosci. 2018;19:470–84.
- 51.
Coccurello R. Anhedonia in depression symptomatology: appetite dysregulation and defective brain reward processing. Behav Brain Res. 2019;372:112041.
- 52.
Loughrey DG, Kelly ME, Kelley GA, Brennan S, Lawlor BA. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018;144:115–26.
- 53.
Fischer ME, Cruickshanks KJ, Schubert CR, Pinto AA, Carlsson CM, Klein BE, et al. Age-related sensory impairments and risk of cognitive impairment. J Am Geriatr Soc. 2016;64:1981–7.
- 54.
Russ TC, Kivimäki M, Batty GD. Respiratory disease and lower pulmonary function as risk factors for dementia: a systematic review with meta-analysis. Chest. 2020;157:1538–58.
- 55.
Grande G, Marengoni A, Vetrano DL, Roso-Llorach A, Rizzuto D, Zucchelli A, et al. Multimorbidity burden and dementia risk in older adults: the role of inflammation and genetics. Alzheimers Dement. 2021;17:768–76.
- 56.
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.
- 57.
Snaith RP, Harrop FM, Newby DA, Teale C. Grade scores of the montgomery—Åsberg depression and the clinical anxiety scales. Br J Psychiatry. 1986;148:599–601.
Acknowledgements
We are grateful to SNAC-K participants and staff members involved in the data collection and management. The SNAC-K study is supported by Swedish Ministry of Health and Social Affairs, the participating County Councils and Municipalities, the Swedish Research Council (grant no.: 2017-06088), and the Swedish Research Council for Health, Working Life and Welfare (grant no.: 2016-07175). FT and SD would like to acknowledge financial support from the Swedish Research Council for Health, Working Life, and Welfare (grant no.: 2019-01076) and the Lindhés Advokatbyrå AB (grant no.: LA2021-0129). LS received research support from the Swedish Research Council (grant no.: 2017-00639). ACL received financial support from the Swedish Research Council (grant no.: 2016-00981) and the Swedish Research Council for Health, Working Life, and Welfare (grant no.: 2017-01764). Last, we would like to express gratitude to the anonymous reviewer for their valuable methodological comments and suggestions during the revision.
Funding
Open access funding provided by Karolinska Institute.
Author information
Affiliations
Contributions
All authors contributed to the study conception and design. FT had full access to all of the study data and take complete responsibility for the integrity of the data and the accuracy of the data analysis. All authors contributed to the interpretation of results. FT and SD drafted the first version of the manuscript. MBM, ACL, DLV, LS, LF, and SD provided critical revision of the manuscript. All authors approved the manuscript in its final version, and agreed to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests in relation to the study. Funding agencies had no involvement in study design, collection, analysis, and interpretation of data.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Triolo, F., Belvederi Murri, M., Calderón-Larrañaga, A. et al. Bridging late-life depression and chronic somatic diseases: a network analysis. Transl Psychiatry 11, 557 (2021). https://ift.tt/2Zwn8i5
-
Received:
-
Revised:
-
Accepted:
-
Published:
"network" - Google News
October 31, 2021 at 01:18AM
https://ift.tt/2Y3HeQu
Bridging late-life depression and chronic somatic diseases: a network analysis | Translational Psychiatry - Nature.com
"network" - Google News
https://ift.tt/2v9ojEM
https://ift.tt/2KVQLik
Bagikan Berita Ini
0 Response to "Bridging late-life depression and chronic somatic diseases: a network analysis | Translational Psychiatry - Nature.com"
Post a Comment